Myeloid cell heterogeneity in lung cancer: implication for immunotherapy.
Saved in:
| Title: | Myeloid cell heterogeneity in lung cancer: implication for immunotherapy. |
|---|---|
| Authors: | Sangaletti S; Department of Research, Molecular Immunology Unit, Fondazione IRCCS Istituto Nazionale Dei Tumori, via Amadeo 42, 20133, Milano, Italy., Ferrara R; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy., Tripodo C; Tumor Immunology Unit, University of Palermo, Palermo, Italy.; FIRC Institute of Molecular Oncology (IFOM), Milano, Italy., Garassino MC; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy., Colombo MP; Department of Research, Molecular Immunology Unit, Fondazione IRCCS Istituto Nazionale Dei Tumori, via Amadeo 42, 20133, Milano, Italy. mariopaolo.colombo@istitutotumori.mi.it. |
| Source: | Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2021 Sep; Vol. 70 (9), pp. 2429-2438. Date of Electronic Publication: 2021 Apr 02. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Springer Verlag Country of Publication: Germany NLM ID: 8605732 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0851 (Electronic) Linking ISSN: 03407004 NLM ISO Abbreviation: Cancer Immunol Immunother Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1432-0851 |
|---|---|
| DOI: | 10.1007/s00262-021-02916-5 |
